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Available online 28 March 2016Bacillus subtilis is a well-characterizedmodel bacterium frequently used for a number of biotechnology and syn-
thetic biology applications. Novel strategies combining the advantages of B. subtilis with the DNA assembly and
editing tools of Escherichia coli are crucial for B. subtilis engineering efforts. We combined Gibson Assembly and
λ red recombineering in E. coliwith RecA-mediated homologous recombination in B. subtilis for bacterial artiﬁcial
chromosome-mediated DNA integration into the well-characterized amyE target locus of the B. subtilis chromo-
some. The engineered integrative bacterial artiﬁcial chromosome iBAC(cav) can accept any DNA fragment for in-
tegration into B. subtilis chromosome and allows rapid selection of transformants by B. subtilis-speciﬁc antibiotic
resistance and the yellow ﬂuorescent protein (mVenus) expression.We used the developed iBAC(cav)-mediated
system to integrate 10 kb DNA fragment from E. coli K12 MG1655 into B. subtilis chromosome. iBAC(cav)-
mediated chromosomal integration approach will facilitate rational design of synthetic biology applications in
B. subtilis.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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The rod-shaped Gram-negative bacterium Escherichia coli and the
Gram-positive bacterium Bacillus subtilis are well characterized model
bacteria frequently used for metabolic engineering and a number of
biotechnology and synthetic biology applications (Schallmey et al.,
2004; Juhas et al., 2013a; Juhas, 2015b; Chen et al., 2013; Yim et al.,
2011; Ajikumar et al., 2010). Although the vast majority of the good
DNA assembly and editing tools are in E. coli, B. subtilis is a better host
for certain applications. B. subtilis can secrete proteins into the medium
andhas been successfully used for the production of a number of industri-
ally relevant bioproducts, such as riboﬂavin (Hao et al., 2013; Manabe
et al., 2013; Zweers et al., 2008). Furthermore, B. subtilis forms dormant
endospores that enable survival in the environments lacking nutrients
(McKenney et al., 2013). B. subtilis is also considered to be a promising
host for the construction of theminimal cell factories (Juhas et al., 2014b).
Novel tools combining the advantages of B. subtiliswith the efﬁcient
and reliable DNA assembly and editing methods available in E. coli are
crucial for B. subtilis engineering efforts.
Integration of genetic circuits into the bacterial chromosome has
numerous advantages over their introduction into the genome on
plasmids. Strategies for E. coli chromosomal integration are usually
based on the λ bacteriophage red recombinase system-mediated. This is an open access article underhomologous recombination (Cunningham et al., 2009; Marcellin et al.,
2010; Das et al., 2010; Juhas et al., 2014a; Juhas and Ajioka, 2015a,
2015b). B. subtilis is a naturally competent bacterium that is readily
transformable with extracellular DNA. DNA is integrated into the
B. subtilis chromosome via RecA-mediated homologous recombination
(Yadav et al., 2014; Shi et al., 2013). The natural competence permits
use of the entire 4.2Mb B. subtilis genome as a vector in the B. subtilis ge-
nome (BGM) vector system (Ogawa et al., 2015). BGM allows stable in-
tegration of large DNA fragments into the B. subtilis chromosome by
homologous recombination (up to 3.5 Mb of Synechocystis PCC6803
DNA has been stably integrated into BGM) (Itaya et al., 2000, 2008;
Yonemura et al., 2007; Kaneko et al., 2003; Iwata et al., 2013; Itaya
et al., 2005). Horizontal gene transfer is mediated by mobile genetic el-
ements, such as plasmids and genomic islands (Juhas, 2015a, 2015d;
Juhas et al., 2007a, 2007b, 2008, 2009, 2013b; Robinson et al., 2010;
Dobrindt et al., 2004, 2010). The integration of DNA fragments into
the B. subtilis chromosome relies often on plasmids that have limited
cloning capacity (Vojcic et al., 2012; Brigidi et al., 1990). Bacterial artiﬁ-
cial chromosomes (BACs) based on the E. coli fertility factor (F-factor)
are frequently used for engineering high molecular weight DNA frag-
ments in E. coli (Hall et al., 2012; Shizuya et al., 1992). BACs are main-
tained in E. coli in the single copy extrachromosomal supercoiled form
and support stable propagation of inserted DNA over multiple genera-
tions (O'Connor et al., 1989; Hall et al., 2012). DNA shuttling between
BACs and BGM was reported previously (Kaneko et al., 2005, 2009).
Integration into BGM requires two DNA sequences, called landing padthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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quences, correctly aligned in an E. coli pBR322 plasmid are introduced
into a pBR sequence locus of the B. subtilis chromosome prior to integra-
tion of DNA (Kaneko et al., 2003; Itaya et al., 2000).
Here we present an alternative approach for simple and reliable
BAC-mediated DNA integration into the B. subtilis chromosome at
well-characterized amyE locus using the engineered integrative
iBAC(cav).
2. Materials and methods
2.1. Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this study are listed in Table 1.
E. coli and B. subtilis strains were routinely grown in Luria-Bertani broth
(LB). For generating competent B. subtilis, cells were cultivated in the
starvation medium as described below. When needed, growth media
were supplemented with ampicillin (100 μg/ml), kanamycin (50 μg/ml)
and chloramphenicol (30 μg/ml) for cultivating E. coli, or kanamycin
(5 μg/ml) and chloramphenicol (5 μg/ml) for growing B. subtilis. Liquid
cultures of E. coli and B. subtilis were grown in LB (supplemented with
the antibiotics when needed) and incubated at 37 °C with shaking at
200 rpm on a rotatory shaker, depending on the requirements. All E. coli
and B. subtilis plate cultures were grown for about 24 h at 37 °C.
2.2. DNA ampliﬁcation and modiﬁcation procedures
PCR ampliﬁcation of DNA sequences was performed in 25 or 50 μl
reaction volumes using Dream Taq master mix kit (Thermo Scientiﬁc)
or Phusion DNA polymerase (Thermo Scientiﬁc) according to the
supplier's speciﬁcations. PCR primers were synthesized by Sigma-
Aldrich. A modiﬁed Gibson Assembly procedure (Gibson et al., 2009;
Merryman and Gibson, 2012) in a 5.2 μl ﬁnal reaction volume was
employed to assembleDNA fragments (Juhas et al., 2014a). The successful
assemblies were validated by PCR ampliﬁcation and sequencing. Stan-
dardized kits were used for extracting DNA fragments from the agaroseTable 1
Bacterial strains, plasmids and BACs used in this study.
Characteristics Reference
Strains
K12 MG1655 E. coli wild type Hayashi et al. (2006)
Bs B. subtilisMarburg wild type
168, trpC2
Burkholder and Giles
(1947)
Bs(cavQS) B. subtilis 168, 10 kb DNA
integrated in amyE locus
This study
Plasmids
pSB1K3 BioBrick assembly plasmid,
kanamycin resistance
parts.igem.org/Part:pSB1K3
pKM208 IPTG-inducible Red
recombinase system
Murphy and Campellone
(2003)
pCP20 Flippase (FLP) recombinase Datsenko and Wanner
(2000)
pSB1K3(FRTK) pSB1K3 with kanamycin
resistance cassette
Juhas et al. (2014a)
pJScav pJS209 plasmid, amyE integr
sites, ven/cat circuits
Lab collection
pSB1K3(FRTKpJScav) pSB1K3(FRTK), amyE integr
sites, ven/cat circuits
This study
BACs
pBeloBAC11 BAC with chloramphenicol
resistance
Lab collection
iBAC(cav)g pBeloBAC11, amyE sites,
ven/cat, Gibson Assem.
This study
iBAC(cav)r pBeloBAC11, amyE sites,
ven/cat, λ red assembled
This study
iBAC(cavQS) iBAC(cav) with 10 kb E. coli
DNA fragment
This studygel (Qiaquick gel extraction kit, Qiagen) and for plasmid isolation
(Qiaprep Spin Miniprep kit, Qiagen), according to the supplier's
instructions. Bacterial artiﬁcial chromosomes were isolated using
Qiaquick gel extraction kit (Qiagen) or PhasePrep BAC DNA kit
(Sigma-Aldrich). B. subtilis genomic DNA was isolated with GeneJET
genomic DNA puriﬁcation kit (Thermo Scientiﬁc) according to
manufacturer's instructions.
2.3. λ red system-mediated DNA integration into BACs
The electro-competent and chemically competent E. coli cells were
produced employing the modiﬁed Miller and Nickoloff (Miller and
Nickoloff, 1995) and Hannah (Hanahan et al., 1991) methods, respec-
tively. Integration into BACs was performed using the streamlined λ
red system-mediated method (Juhas et al., 2014a; Juhas and Ajioka,
2015a, 2015b). Brieﬂy, E. coli harbouring BAC was transformed with
plasmid pKM208 encoding the IPTG-inducible λ red system and incu-
bated on ampicillin plates at 30 °C. Overnight culture of the pKM208-
harbouring E. coli K12 MG1655 was inoculated into LB with ampicillin
(1:100 dilution) and grown at 30 °C. After reaching OD600 0.2, IPTG
(1 mM) has been added and the bacterial culture was grown to the
ﬁnal OD600 0.5. Cells were washed twice and resuspended in 100 μl of
10% glycerol per 100ml of starting culture volume. 100 μl of the gel pu-
riﬁed DNA fragment ﬂanked by sequences of the integration target on
BAC was electroporated into pKM208-harbouring electrocompetent
cells. Transformants were selected on LB plates with kanamycin
(50 μg/ml) and grown at 37 °C overnight and then incubated at 42 °C
overnight to cure out pKM208 plasmid. Integrations were conﬁrmed
by diagnostic PCR using ﬂanking primers and sequencing.
2.4. Pulsed ﬁeld gel electrophoresis analysis (PFGE) of BACs
Samples were loaded into the wells of a 1% pulsed ﬁeld certiﬁed
agarose gel in TBE buffer (BioRad Laboratories). The gel was then placed
into the electrophoresis chamber of a CHEF DR II (BioRad Laboratories)
PFGE apparatus ﬁlled with 0.5 × TBE buffer. The PFGE was run with the
following electrophoretic conditions: run time of 11 h, switch time of
0.5–5 s, voltage gradient of 6 V/cm. The running temperature of 14 °C
was provided by using thewater pump and the coolingmodule (BioRad
Laboratories). 8–48 kb CHEF DNA size Ladder (BioRad Laboratories) has
been used as the molecular weight marker for PFGE. Following elec-
trophoresis, the gel was stained with the SYBR®Safe DNA gel dye
(Invitrogen) and DNA fragments were visualized with Safe Imager
blue-light transilluminator.
2.5. Generation and transformation of competent B. subtilis cells
To generate competent B. subtilis cells, single colonywas ﬁrst inocu-
lated into 10mlminimalmedium composed of 2ml of 5×minimal salts
solution (2 g ammonium sulphate, 14.8 g potassium hydrogen phos-
phate, 5.4 g potassium dihydrogen phosphate, 1.9 g sodium citrate,
0.2 g magnesium sulphate heptahydrate dissolved in 200 ml of
deionised water), 0.1 ml glucose (50% w/v), 0.1 ml casamino acids (2%
w/v), 0.02 ml tryptophan (10 mg/ml), 0.01 ml iron ammonium citrate
(2.2 mg/ml) in a deionised water. Inoculated cells were grown at
200rpm on a rotatory shaker at 37 °C for 18 h. Then, 1.4 ml of the
B. subtilis culture was inoculated into 10 ml of the fresh minimal medi-
um and grown for another 3 h. Subsequently, 11 ml of the starvation
medium composed of 2.2 ml of 5× minimal salt solution and 0.11 ml
glucose (50% w/v) in a deionised water was added to the B. subtilis cul-
ture and cells were grown for additional 2 h and 45min. 0.3 ml aliquots
were transferred into 15 ml polypropylene tubes and transformed with
15 μl of BAC DNA or plasmid DNA. Transformed B. subtilis cells were in-
cubated at 37 °C with shaking at 200 rpm on a rotatory shaker for 1 h
prior to the addition of 700 μl LB. Cells were then continued to grow
for 1.5–2 h. 20–200 μl of this culture was plated onto selection plates
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were conﬁrmed by diagnostic PCR and sequencing.
2.6. Fluorescence measurement with the microplate reader
Fluorescence was quantiﬁed in the ﬂat-bottomed black 96 well
plates (Greiner BioOne, UK). B. subtilis cultures were grown overnight
and then normalized to OD600 of 0.05. 200 μl of these diluted cultures
was aliquoted into themicroplatewells and incubated in themicroplate
reader (Fluostar Omega, BMG Labtech, UK) at 37 °C for 10 h. mVenus
ﬂuorescence was measured with the automatically repeated protocol
(excitation ﬁlter 485–12, emission ﬁlter 530–10, gain 1200, double or-
bital shaking at 200 rpm, and cycle time 60 min). The mean and stan-
dard errors were calculated from three biological replicates.
2.7. Microplate reader measurement of the absorbance
Absorbance was measured in the ﬂat-bottomed clear 96 well plates
(Sterilin Sero-Well, UK). The overnight B. subtilis cultures were diluted
to OD600 of 0.05 and 200 μl of these normalized cultures per microplate
well was incubated in the microplate reader (Fluostar Omega, BMG
Labtech, UK) at 37 °C for 24 h. Absorbancewasmeasuredwith the auto-
matically repeated protocol with the following parameters (cycle time
60 min, double orbital shaking at 500 rpm, 600 nm absorbance ﬁlter).
The experiment was carried out in triplicate.
2.8. Databases and sequence analyses
The National Center for Biotechnology Information (NCBI) website
(http://ncbi.nlm.nih.gov) was exploited to compare DNA sequences
using the BLASTN (Altschul et al., 1990), TBLASTX and position-speciﬁcFig. 1. Plasmid and BAC maps. Figure shows the maps of the key plasmids and BACs used in thi
genetic circuits (B) pSB1K3(FRTKpJScav): intermediate for the λ red recombineering-based
Isothermal Assembly harbours ampicillin resistance gene. (D) iBAC(cav)r: iBAC(cav) constructiterated BLAST (PSI-BLAST) algorithms (Altschul et al., 1997). The se-
quences of the pJS209 and pSB1K3 plasmids and BAC pBeloBAC11 were
obtained from the websites of the Registry of Standard Biological Parts
(http://parts.igem.org/Main_Page) and the Addgene nonproﬁt plasmid
repository (http://www.addgene.org/), respectively. The Registry of Stan-
dard Biological Parts is a repository of genetic parts that can bemixed and
matched to build systems for synthetic biology applications. The E. coli
genome sequence was obtained from the E. coli K-12 project website
(http://www.xbase.ac.uk/genome/escherichia-coli-str-k-12-substr-
mg1655). The B. subtilis genome sequence was obtained from the
BioCyc (http://bsubcyc.org/) and SubtiWiki (http://subtiwiki.uni-
goettingen.de/) databases. Sequencing of DNA constructs was per-
formed by Source Bioscience.
3. Results and discussion
3.1. B. subtilis integrative bacterial artiﬁcial chromosome iBAC(cav)
construction
To integrate synthetic DNA into B. subtilis, we engineered the well-
characterized BAC pBeloBAC11 by inserting sequences homologous to
amyE target locus on the B. subtilis chromosome from the plasmid
pJScav (Table 1 and Fig. 1A). Two amyE integration target sequences
were introduced into pBeloBAC11, the leading (5′) sequence amyE1
and the trailing (3′) sequence amyE2 (Figs. 1A–D and 2). The amyE1
and amyE2 are 521 bp and 1029 bp long, respectively. Linear DNA
inserted between amyE1 and amyE2 sequences will integrate into
B. subtilis by double-crossover recombination events between the chro-
mosomal amyE of B. subtilis and amyE1,2 sequences (Overkamp et al.,
2013). Furthermore, we introduced two genetic circuits (ven and cat)
into pBeloBAC11 between two ﬂanking amyE integration sequences.s study. (A) pJScav: source of the amyE locus integration target sequences and cat and ven
approach of iBAC(cav)r construction. (C) iBAC(cav)g: iBAC(cav) generated by Gibson
ed using λ red recombineering harbours kanamycin resistance gene.
Fig. 2. iBAC-mediated chromosomal integration strategy. Figure shows themain steps of the iBAC-mediated DNA integration into B. subtilis chromosome (A) PCR ampliﬁcation of the DNA
fragment and kanamycin resistance cassette ﬂanked by sequences homologous to the integration target locus on iBAC(cav). FRT sites in the kanamycin resistance cassette allow ﬂipping
out of the kanamycin marker by FLP recombinase. (B) Electroporation of the DNA fragment into E. coli harbouring iBAC(cav) and pKM208-bourne IPTG-inducible λ red system.
(C) Integration of the DNA fragment into iBAC(cav) by λ red system-mediated homologous recombination. (D) Curing out of pKM208. (E) Transformation of B. subtiliswith iBAC(cav)
harbouring the DNA fragment. (F) Integration of the DNA fragment into B. subtilis chromosome by homologous recombination.
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and the yellow ﬂuorescent protein-encoding mVenus (Nagai et al.,
2002; Yansura and Henner, 1984). The genetic circuit cat harbours the
chloramphenicol resistance-encoding gene under the control of the
constitutive Bacillus-speciﬁc promoter from the Registry of Standard Bi-
ological Parts (http://parts.igem.org/Main_Page). The genetic circuits
ven and cat introduced into pBeloBAC11 are isolated on both ends
with terminators from the Registry of Standard Biological Parts.
The engineered iBAC(cav) allows rapid selection of transformants
by Bacillus-speciﬁc chloramphenicol resistance andmVenus expression.
We used two different approaches, Gibson Isothermal Assembly
(Gibson et al., 2009; Merryman and Gibson, 2012) and λ red
recombineering (Datsenko and Wanner, 2000; Sabri et al., 2013;
Ublinskaya et al., 2012) to assemble iBAC(cav). In the former approach,
PCR ampliﬁed pBeloBAC11 backbone and the genetic circuits ven
and cat ﬂanked by amyE integration target sites in addition to the
ampicillin resistance encoding gene bla (Fig. 1A) were joined to gen-
erate iBAC(cav)g (Fig. 1C). The construction of iBAC(cav)g was ver-
iﬁed by diagnostic PCR with ﬂanking primers for each part and
sequencing. Furthermore, E. coli harbouring correctly assembled
iBAC(cav)g grew on a selective medium containing chlorampheni-
col and expressedmVenus encoding the yellow ﬂuorescent protein. The
second iBAC(cav)r (Fig. 1D) was generated by λ red recombineering. λ
red recombineering allows integration by incorporating sequences at
both ends of the DNA fragment that are homologous to the integration
target site. The inhibition of the host's RecBCD exonuclease V by the
Gam protein of the λ red system allows proteins Bet and Exo contact
with the homologous sequences at the ends of the DNA fragment to pro-
mote recombination.We used our developed streamlined λ red recombi-
nation approach (Juhas et al., 2014a) to construct iBAC(cav)r (Fig. 1D).
First, we generated plasmid pSB1K3(FRTKpJScav) (Fig. 1B) by introducing
the DNA fragment harbouring the genetic circuits ven and cat ﬂanked by
amyE integration target sites into pSB1K3(FRTK) (Juhas et al., 2014a).
Then, we integrated the DNA fragment into pBeloBAC11 using λ
red system-mediated homologous recombination. We used thesetwo approaches to introduce different resistance markers, ampicil-
lin and kanamycin into iBAC(cav)g into iBAC(cav)r, respectively.
The construction of plasmid pSB1K3(FRTKpJScav), iBAC(cav)g and
iBAC(cav)r was conﬁrmed by PCR with ﬂanking primers and se-
quencing. The integration and diagnostic ﬂanking primers used are
listed in Supplementary Table 1. Construction of iBAC(cav)g and
iBAC(cav)r was further veriﬁed by pulsed ﬁeld gel electrophoresis
(PFGE) (Supplementary Fig. 1). DNA bands obtained in the PFGE ex-
periment after digesting iBAC(cav)g and iBAC(cav)r with BamHI and
XhoI restriction endonucleases had the correct molecular weight
(Supplementary Fig. 1).
3.2. iBAC-mediated B. subtilis chromosomal integration strategy
The general strategy of our iBAC-mediated chromosomal integration
strategy is shown in Fig. 2. First, the DNA fragment to be integrated is
cloned into plasmid pSB1K3(FRTK) (Juhas et al., 2014a) next to the
kanamycin resistance cassette. The kanamycin resistance gene in the
cassette is ﬂanked by FRT (ﬂippase recognition target) sites. Second,
the PCR ampliﬁed DNA fragment with the kanamycin resistance cas-
sette is electroporated into E. coli harbouring iBAC(cav) and pKM208-
bourne λ red system that mediates homologous recombination into
iBAC(cav). Third, iBAC(cav) harbouring DNA fragment is transformed
into B. subtilis and DNA fragment is integrated into the target amyE
locus (Yang et al., 2013) of the B. subtilis chromosome by RecA-
mediated homologous recombination (Fig. 2) (Yadav et al., 2014; Shi
et al., 2013). Transformants are identiﬁed by Bacillus-speciﬁc chloram-
phenicol resistance andmVenus expression and conﬁrmed bydiagnostic
PCR and sequencing. λ red recombineering has many advantages over
other DNA assembly methods, such as Gibson Isothermal Assembly
(Juhas andAjioka, 2016).Weusedλ red recombineering approachmainly
due to its potential to assemble very largeDNA fragments. The FRT sites in
the kanamycin resistance cassette introduced into iBAC(cav) allow ﬂip-
ping out of the kanamycin marker from iBAC(cav) by ﬂippase (FLP)
recombinase and subsequent integration of other DNA fragments.
Fig. 3. Growth and mVenus expression of B. subtilis with chromosomal integration.
(A) Integration of DNA fragment into amyE locus of the B. subtilis chromosome does not
have negative impact on growth. (B) Quantitative veriﬁcation of the integrated genetic
circuit ven expression by measuring mVenus ﬂuorescence over time with the microplate
reader (Fluostar Omega, BMG Labtech, UK). The initial absorbance of the analyzed
strains at 600 nm (OD600) was 0.05. The experiments were carried out in triplicate,
error bars represent standard errors. Bs: B. subtilis wild type strain 168, Bs(cavQS):
engineered B. subtilis strain 168 with 10 kb DNA fragment from E. coli.
Fig. 4. iBAC-mediated chromosomal integration efﬁciency. Figure shows B. subtilis
chromosomal integration efﬁciency calculated from the number of the colony forming
units per μg of electroporated DNA for circular and linear iBAC(cavQS). C: uncut
iBAC(cavQS), RD: iBAC(cavQS) linearised by restriction digest, PCR: PCR ampliﬁed DNA
fragment from iBAC(cavQS). The mean and standard errors were calculated from three
independent replicates.
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The constructed iBAC(cav) (Fig. 1C and D) can be used for the inte-
gration of any DNA fragment into B. subtilis chromosome. To conﬁrm
its suitability for chromosomal integration, we cloned 10 kb DNA frag-
ment from E. coli K12 MG1655 into iBAC(cav). The constructed
iBAC(cavQS) harbouring cloned 10 kb DNA fragment was transformed
into the recipient B. subtilis as described in Section 2. The exact position
within the amyE locus where chromosomal integration occurred is
shown in Supplementary Fig. 2. Integration of the DNA fragment into
the targeted amyE regionwas veriﬁed by diagnostic PCR and sequencing
(Supplementary Fig. 3 and Supplementary Table 1). We chose amyE
locus as integration target mainly because it is well-characterized,
non-essential and widely conserved in a number of B. subtilis strains
(Voigt et al., 2009; Jeong et al., 2015; Juhas et al., 2011, 2012a, 2012b,
2014b; Juhas, 2015b, 2015c; Lajoie et al., 2013; Glass, 2012). To verify
the non-essentiality of amyE, we compared the growth of the
engineered B. subtilis strain Bs(cavQS) harbouring integrated DNA frag-
mentwith that of thewild type (Bs) (Fig. 3A). The integration generated
viable B. subtilis. The growth rate of the engineered B. subtilis strain
Bs(cavQS) was not affected compared to the wild type (Fig. 3A). The in-
tegration of the genetic circuit catwith the 10 kbDNA fragment allowed
selection of transformants by Bacillus-speciﬁc chloramphenicol resis-
tance. The integration of the genetic circuit ven allowed rapid identiﬁca-
tion of transformants byﬂuorescent proteinmVenus expression. Besides
qualitative conﬁrmation by visual observation, the expression of thegenetic circuit ven was conﬁrmed also quantitatively by measuring
mVenus-induced ﬂuorescence over time with the microplate reader
(Fig. 3B).
3.4. iBAC chromosomal integration efﬁciency
The transformation efﬁciency is considered to be among the main
bottlenecks in the directed B. subtilis evolution (Vojcic et al., 2012).
The B. subtilis transformation efﬁciency is dependent on the strain
and method employed and was shown to vary from about 100–
200 transformants per μg DNA for transformation on solid media to
about 1.4 × 107 for transformation of B. subtilis protoplasts in the pres-
ence of polyethylene glycol (Hauser and Karamata, 1994; Akamatsu
and Taguchi, 2001; Chang and Cohen, 1979).
To analyse the iBAC-mediated B. subtilis integration efﬁciency we
measured efﬁciency of chromosomal integration of the engineered
iBAC(cavQS) into amyE locus (Fig. 4). Transformation of B. subtilis
using circular DNA often tends to produce Campbell-type integration
(Young, 1983) at single homologous region. This type of integration is
not suitable for B. subtilis integration due to its high instability. To miti-
gate against the undesired Campbell-type integration, we performed
the B. subtilis chromosomal integration with iBAC(cavQS) linearised by
restriction digest and with PCR ampliﬁed DNA fragment located be-
tween amyE1 and amyE2 integration sequences of iBAC(cavQS), in addi-
tion to the uncut iBAC(cavQS). The integrations using linear DNA
fragments occur by double-crossover recombination events be-
tween the chromosomal amyE of B. subtilis and amyE1,2 sequences.
Chromosomal integrations were conﬁrmed by diagnostic PCR and
the integration efﬁciencies were calculated from the number of
colony-forming units (CFU) per microgram of transformed DNA.
Notably, the integration efﬁciencies differed between the DNA templates
(Fig. 4). The integration efﬁciency with the uncut iBAC(cavQS) was
approximately 15 times higher than integration using iBAC(cavQS)
linearised by restriction digest and PCR ampliﬁed DNA fragment. This
could be due to Campbell-type integration of the circular iBAC(cavQS).
The chromosomal integration efﬁciency of the uncut iBAC(cavQS)
(1.5 × 104 transformants/μg electroporated DNA) was comparable to
that achieved with the small plasmid pVE18 using electroporation meth-
od in a previous study (Brigidi et al., 1990; Vojcic et al., 2012).
4. Conclusions
Novel strategies combining the advantages of B. subtiliswith the ef-
ﬁcient and reliable DNA assembly and editing tools of E. coli are crucial
for B. subtilis engineering efforts. The integration of DNA edited in
E. coli into B. subtilis chromosome is crucial for the development of a
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BAC-mediated method for DNA integration into the B. subtilis chromo-
some. Our method beneﬁts from the DNA assembly and editing
tools available in E. coli, such as λ red recombineering (Datsenko and
Wanner, 2000). We constructed iBAC(cav) by introducing sequences ho-
mologous to the amyE integration target locus on the B. subtilis chromo-
some and genetic circuits cat and ven. The genetic circuits ven and cat
allow easy identiﬁcation of transformants with B. subtilis-speciﬁc chlor-
amphenicol resistance andmVenus expression.
To test the engineered iBAC(cav)-mediated system we integrated
10 kb DNA fragment from E. coli into the B. subtilis chromosome. The
chromosomal integration efﬁciency using iBAC(cav)-mediated system
is comparable to that achieved with plasmids by electroporation; how-
ever, iBAC(cav) provides much larger cloning capacity. Although BGM
can accommodate stable integration of even larger DNA fragments
(Itaya et al., 2005, 2008; Iwata et al., 2013; Kaneko et al., 2005, 2009),
previous integration methods required two landing pad sequences to
determine the cloned region. The landing pad sequences, correctly
aligned in an E. coli pBR322 plasmid were introduced into a pBR se-
quence locus of the B. subtilis chromosome prior to cloning (Kaneko
et al., 2003; Itaya et al., 2000). Our iBAC(cav)-mediated systemprovides
an alternative to other B. subtilis chromosome integration approaches. It
does not require introduction of the landing pad sequences integrated
at the target site before cloning and allows easy identiﬁcation of
transformants by ﬂuorescent protein expression. Our system will facili-
tate rational design of synthetic biology devices in B. subtilis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.mimet.2016.03.017.
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